Vivani Current Deferred Revenue from 2010 to 2026
| VANI Stock | USD 1.19 0.00 0.00% |
Current Deferred Revenue | First Reported 2013-12-31 | Previous Quarter -570 K | Current Value -645 K | Quarterly Volatility 1.4 M |
Check Vivani Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vivani Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 408.7 K, Interest Expense of 8.9 M or Selling General Administrative of 7.9 M, as well as many indicators such as Price To Sales Ratio of 89.89, Dividend Yield of 0.0 or PTB Ratio of 3.42. Vivani financial statements analysis is a perfect complement when working with Vivani Medical Valuation or Volatility modules.
Vivani | Current Deferred Revenue | Build AI portfolio with Vivani Stock |
The Current Deferred Revenue trend for Vivani Medical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Vivani Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Vivani Medical's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Vivani Medical over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Vivani Medical's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vivani Medical's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Vivani Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 434,233 | |
| Coefficient Of Variation | 260.27 | |
| Mean Deviation | 498,903 | |
| Median | 301,500 | |
| Standard Deviation | 1,130,167 | |
| Sample Variance | 1.3T | |
| Range | 5.5M | |
| R-Value | (0.16) | |
| Mean Square Error | 1.3T | |
| R-Squared | 0.03 | |
| Significance | 0.53 | |
| Slope | (36,728) | |
| Total Sum of Squares | 20.4T |
Vivani Current Deferred Revenue History
About Vivani Medical Financial Statements
Investors use fundamental indicators, such as Vivani Medical's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Vivani Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 301.5 K | 400.7 K |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Vivani Medical Correlation against competitors. For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is there potential for Biotechnology market expansion? Will Vivani introduce new products? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Vivani Medical requires distinguishing between market price and book value, where the latter reflects Vivani's accounting equity. The concept of intrinsic value - what Vivani Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Vivani Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Vivani Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.